Press Releases

GHENT, Belgium, Aug. 19, 2019 /PRNewswire/ -- ActoBio Therapeutics, Inc., a wholly owned subsidiary of Intrexon Corporation (NASDAQ: XON) and innovative clinical-stage biote

OAK BROOK, Ill., Aug. 19, 2019 /PRNewswire/ -- Rewarding children for lost teeth is an age-old tradition … and a little more complex of a job than the Tooth Fairy lets on. The Original Tooth Fairy Poll®, sponsored by Delta Dental, indicates that several circumstances may determine the amount the Tooth Fairy gifts. The No. 1 guiding factor is how much spa

VAUGHAN, ON, Aug. 19, 2019 /PRNewswire/ - CannTrust Holdings Inc. ("CannTrust" or the "Company", TSX: TRST, NYSE: CTST) has received a notice from the Ontario Cannabis Store (the "OCS"), the Crown corporation in charge of wholesale distribution of cannabis products to licensed cannabis retailers in Ontario and the operator of

SANTA CLARA, Calif., Aug. 19, 2019 /PRNewswire/ -- As processes in the upstream pharmaceutical manufacturing workflow change, the consequent variation in cell culture fluid will have significant consequences for downstream purification unit operations. Cell culture fluid harvesting and clarification (H&C) are crucial unit operations

KELOWNA, BC, Aug. 19, 2019 /PRNewswire/ - Valens GroWorks Corp. (TSXV: VGW) (OTCQX: VGWCF) (the "Company" or "Valens"), a vertically integrated provider of industry leading extraction products and services; including a diverse suite of extraction methodologies, next generation cannabinoid delivery formats and an ISO 17025 accredited analyt

NYSE | TSX : ACB                                                                      

TORONTO, Aug. 19, 2019 /PRNewswire/ - MolecuLight Inc., the world's leader in handheld fluorescence imaging for real-time visualization of bacteria for chronic wounds, announced it has secured a $7.5 million USD term loan from Oxford Finance LLC, a specialty finance firm providing senior debt to life sciences and healthcare services compani

WASHINGTON, Aug. 19, 2019 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that on August 16 2019, it received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) as part of its ongoing review of Vanda's supplemental New Drug Application (sNDA) for HETLIOZ® (tasimelteon) for the treatment

LOS ANGELES, Aug. 19, 2019 /PRNewswire/ -- Launched in The New York Times Magazine, Possible Plan (www.possibleplan.org) is a new organization set to become a 501(c)3 that will faci

ISFIYA, Israel, Aug. 19, 2019 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK) (NASDAQ: CHEKW), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of the C-Scan® System, the first and only preparation-free ingestible scanning